188 related articles for article (PubMed ID: 35771397)
1. Mechanisms of cancer cell killing by metformin: a review on different cell death pathways.
Wu XY; Xu WW; Huan XK; Wu GN; Li G; Zhou YH; Najafi M
Mol Cell Biochem; 2023 Jan; 478(1):197-214. PubMed ID: 35771397
[TBL] [Abstract][Full Text] [Related]
2. Induction of Cancer Cell Death by Apigenin: A Review on Different Cell Death Pathways.
Amini P; Moazamiyanfar R; Dakkali MS; Jafarzadeh E; Ganjizadeh M; Rastegar-Pouyani N; Moloudi K; Khodamoradi E; Taeb S; Najafi M
Mini Rev Med Chem; 2023; 23(14):1461-1478. PubMed ID: 36658710
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Cancer-killing by Quercetin; A Review on Cell Death Mechanisms.
Wang H; Dong Z; Liu J; Zhu Z; Najafi M
Anticancer Agents Med Chem; 2023; 23(9):999-1012. PubMed ID: 36683373
[TBL] [Abstract][Full Text] [Related]
4. Patterns of cell death induced by metformin in human MCF-7 breast cancer cells.
Dias Lopes NM; Marinello PC; Sanches LJ; da Silva Brito WA; Lovo-Martins MI; Pinge-Filho P; Luiz RC; Cecchini R; Cecchini AL
Pathol Res Pract; 2020 Nov; 216(11):153199. PubMed ID: 32932214
[TBL] [Abstract][Full Text] [Related]
5. Targeting of cancer cell death mechanisms by resveratrol: a review.
Fu X; Li M; Tang C; Huang Z; Najafi M
Apoptosis; 2021 Dec; 26(11-12):561-573. PubMed ID: 34561763
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of cancer cell death induction by triptolide.
AbdulHussein AH; Al-Taee MM; Radih ZA; Aljuboory DS; Mohammed ZQ; Hashesh TS; Riadi Y; Hadrawi SK; Najafi M
Biofactors; 2023; 49(4):718-735. PubMed ID: 36876465
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of cancer cell death induction by paclitaxel: an updated review.
Zhao S; Tang Y; Wang R; Najafi M
Apoptosis; 2022 Oct; 27(9-10):647-667. PubMed ID: 35849264
[TBL] [Abstract][Full Text] [Related]
8. Activation of autophagy flux by metformin downregulates cellular FLICE-like inhibitory protein and enhances TRAIL- induced apoptosis.
Nazim UM; Moon JH; Lee JH; Lee YJ; Seol JW; Eo SK; Lee JH; Park SY
Oncotarget; 2016 Apr; 7(17):23468-81. PubMed ID: 26992204
[TBL] [Abstract][Full Text] [Related]
9. Autophagy and protein kinase RNA-like endoplasmic reticulum kinase (PERK)/eukaryotic initiation factor 2 alpha kinase (eIF2α) pathway protect ovarian cancer cells from metformin-induced apoptosis.
Moon HS; Kim B; Gwak H; Suh DH; Song YS
Mol Carcinog; 2016 Apr; 55(4):346-56. PubMed ID: 25663310
[TBL] [Abstract][Full Text] [Related]
10. The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells.
Ben Sahra I; Tanti JF; Bost F
Autophagy; 2010 Jul; 6(5):670-1. PubMed ID: 20559023
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of midkine by metformin can contribute to its anticancer effects in malignancies: A proposal mechanism of action of metformin in context of endometrial cancer prevention and therapy.
Karadeniz Z; Aynacıoğlu AŞ; Bilir A; Tuna MY
Med Hypotheses; 2020 Jan; 134():109420. PubMed ID: 31634770
[TBL] [Abstract][Full Text] [Related]
12. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.
Zhang T; Wang X; He D; Jin X; Guo P
Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080
[TBL] [Abstract][Full Text] [Related]
13. Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt.
Janjetovic K; Vucicevic L; Misirkic M; Vilimanovich U; Tovilovic G; Zogovic N; Nikolic Z; Jovanovic S; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
Eur J Pharmacol; 2011 Jan; 651(1-3):41-50. PubMed ID: 21114978
[TBL] [Abstract][Full Text] [Related]
14. Nobiletin as an inducer of programmed cell death in cancer: a review.
Huang J; Chang Z; Lu Q; Chen X; Najafi M
Apoptosis; 2022 Jun; 27(5-6):297-310. PubMed ID: 35312885
[TBL] [Abstract][Full Text] [Related]
15. Metformin represses glucose starvation induced autophagic response in microvascular endothelial cells and promotes cell death.
Samuel SM; Ghosh S; Majeed Y; Arunachalam G; Emara MM; Ding H; Triggle CR
Biochem Pharmacol; 2017 May; 132():118-132. PubMed ID: 28274614
[TBL] [Abstract][Full Text] [Related]
16. Metformin prevents cell tumorigenesis through autophagy-related cell death.
De Santi M; Baldelli G; Diotallevi A; Galluzzi L; Schiavano GF; Brandi G
Sci Rep; 2019 Jan; 9(1):66. PubMed ID: 30635619
[TBL] [Abstract][Full Text] [Related]
17. Anti-diabetic drug metformin: challenges and perspectives for cancer therapy.
Snima KS; Pillai P; Cherian AM; Nair SV; Lakshmanan VK
Curr Cancer Drug Targets; 2014; 14(8):727-36. PubMed ID: 25329671
[TBL] [Abstract][Full Text] [Related]
18. The protective role of metformin in autophagic status in peripheral blood mononuclear cells of type 2 diabetic patients.
Bhattacharya D; Dutta M; Mukhopadhyay M; Bhattacharyya M; Chowdhury S; Karmakar P
Cell Biol Int; 2020 Aug; 44(8):1628-1639. PubMed ID: 32237184
[TBL] [Abstract][Full Text] [Related]
19. Metformin - its potential anti-cancer and anti-aging effects.
Podhorecka M; Ibanez B; Dmoszyńska A
Postepy Hig Med Dosw (Online); 2017 Mar; 71(0):170-175. PubMed ID: 28258677
[TBL] [Abstract][Full Text] [Related]
20. Metformin induces both caspase-dependent and poly(ADP-ribose) polymerase-dependent cell death in breast cancer cells.
Zhuang Y; Miskimins WK
Mol Cancer Res; 2011 May; 9(5):603-15. PubMed ID: 21422199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
